Product Information

HYDROMORPHONE HCL ER 8 MG TAB is a generic product labeled by Trigen Laboratories, LLC, priced at $6.0373 per EA under NDC 13811070110. Its NADAC has been published 285 times since Jan 11, 2017.

The High Outlier badge above means this manufacturer's average price in the Hydromorphone Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

HYDROMORPHONE HCL ER 8 MG TAB

Hydromorphone Hydrochloride
$6.0373per EA
High Outlier
DEA Schedule CII

Strength

8 mg/1

NDC

13811070110

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

HYDROMORPHONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA205629

On Market Since

9/15/2016

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price Statistics

The NADAC for HYDROMORPHONE HCL ER 8 MG TAB has been published 285 times since Jan 11, 2017, and over the history we have for it it has declined 28.1%. The table below summarizes its recorded NADAC range and movement.

Current price$6.0373 per EA
All-time high$9.1937 (Apr 12, 2017)
All-time low$3.0250 (Mar 20, 2024)
52-week high$7.0165
52-week low$6.0373
Median price$6.4664
Average price$6.1126
Largest weekly change-53.2% (Jun 21, 2023)
Weeks tracked285
Tracking sinceJan 11, 2017

Price History

1W

0.0%

1M

-6.2%

3M

-14.0%

6M

-5.7%

1Y

-7.1%

3Y

+84.5%

5Y

-13.7%

All

-28.1%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 91% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 91%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of HYDROMORPHONE HCL ER 8 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for HYDROMORPHONE HCL ER 8 MG TAB, manufactured by Trigen Laboratories, LLC, is $6.0373 per EA (NDC 13811070110), effective Jun 24, 2026.

How has the price of HYDROMORPHONE HCL ER 8 MG TAB changed over time?

Over the history we have for it, the NADAC for HYDROMORPHONE HCL ER 8 MG TAB has declined 28.1%. It has been tracked across 285 weekly CMS publications since Jan 11, 2017.

What are the highest and lowest recorded NADAC prices for HYDROMORPHONE HCL ER 8 MG TAB?

Since Jan 11, 2017, the NADAC for HYDROMORPHONE HCL ER 8 MG TAB has ranged from a low of $3.0250 (Mar 20, 2024) to a high of $9.1937 (Apr 12, 2017), with a median of $6.4664 per EA.

Are there cheaper alternatives to HYDROMORPHONE HCL ER 8 MG TAB?

Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, HYDROMORPHONE 8 MG TABLET, is $0.5665 per EA — about 91% below HYDROMORPHONE HCL ER 8 MG TAB.

Who manufactures HYDROMORPHONE HCL ER 8 MG TAB?

HYDROMORPHONE HCL ER 8 MG TAB (NDC 13811070110) is labeled by Trigen Laboratories, LLC, and CMS classifies it as a generic product.